Delivery Order SPE2DB25D3306-SPE2DB25FUBXD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,776.45 on June 11, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 12, 2025, to be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $1,783.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract through open competition. The order is scheduled for completion by July 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count units) valued at $1,488.86. This firm fixed-price delivery order is expected to reach completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $23,960.12. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by December 2, 2025, and will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $104,283.60 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count units). This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $8,006.80. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 tablets of Abiraterone Acetate 250 mg with a ceiling value of $18,846.32. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 23, 2025, issued on September 22, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count units) with a ceiling value of $15,739.23. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 tablets of Abiraterone Acetate 250 mg, valued at $13,450.30, with an ultimate completion date of July 31, 2025. This competitive award, issued as a firm fixed-price delivery order, is being performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $13,523.01 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Abiraterone Acetate 500 mg tablets in quantities of 60 units. This firm fixed-price contract, which is not set-aside, is scheduled for completion by December 4, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. As a non-set-aside award, the contract was competitively procured and reflects AmerisourceBergen's demonstrated...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBXDDelivery Order
The Defense Logistics Agency awarded a $4,239.73 delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count package). This contract is a firm fixed price delivery order with an ultimate completion date of June 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies critical medications and medical commodities to support military healthcare systems and federal medical procurement needs. The Abiraterone Acetate medication being procured is a prescription pharmaceutical commonly used in oncology treatment, reflecting the company's role in delivering specialized healthcare products across multiple therapeutic domains to the Department of Defense and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 6/5/25 |